Back to Geriatrics
Geriatricsv2.4Evidence-Based

DexaMed Geriatric Medication Guard v2.4

Deterministic rule-based clinical evaluation for geriatric medication safety, screening potentially inappropriate medications (PIMs) based on the 2023 AGS Beers Criteria, CNS polypharmacy risk, Cockcroft-Gault renal dosing, and Anticholinergic Cognitive Burden (ACB) scoring.

Clinical Input Parameters

years
Range: 0 — 125 years
kg
Range: 10 — 400 kg
mg/dL
Range: 0.1 — 25 mg/dL
Clinical Assessment
Awaiting Parameters
geriatric guard summary
—findings
Ready to Calculate

Awaiting Clinical Input

Enter the clinical input parameters on the left and click Run Clinical Assessment to evaluate this medical calculator with deterministic clinical scoring.

Open in Web App
Clinical decision support tool for licensed medical practitioners. Confirm independently before prescribing or clinical action.

When & Why to Use

The DexaMed Geriatric Medication Guard v2.4 is utilized in clinical practice for risk stratification, diagnostic probability estimation, and treatment decision-making within geriatrics.

Use this tool during initial patient intake, emergency department workup, or bedside assessment when objective clinical scoring is required to guide management or admission decisions.

Clinical Formula & Scoring Logic

2023 AGS Beers Criteria (Tables 2, 3, 4, 5, 6) & Indiana University Anticholinergic Cognitive Burden (ACB) Scale 2008. Cockcroft-Gault CrCl = [(140 - Age) * Weight(kg) * (0.85 if female)] / [72 * SCr(mg/dL)].

Clinical Pearls & Practice Notes

  • 100% deterministic rule-based clinical engine without heuristic estimation.
  • Beers Criteria identify potentially inappropriate medications (PIMs) and do not represent absolute contraindications.
  • In palliative and hospice care, patient comfort goals take precedence over standard Beers recommendations.
  • Baclofen renal dosing is evaluated exclusively based on eGFR < 60 mL/min/1.73m²; other renal medications are evaluated based on CrCl.
  • Corticosteroid + NSAID co-administration is reported as a supplementary DexaMed safety rule rather than official AGS Table 5.

Evidence & Literature Citations

  1. 2023 American Geriatrics Society Beers Criteria Update Expert Panel. American Geriatrics Society 2023 updated AGS Beers Criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2023;71(7):2052-2081. doi:10.1111/jgs.18372
  2. Boustani M, Campbell N, Munger S, Maidment I, Fox C. Impact of anticholinergics on cognition. Indiana University Center for Aging Research. 2008.
  3. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16(1):31-41.

Score Interpretation Ranges

No Implemented Findings≤ pts

No implemented screening rules triggered

Moderate Anticholinergic Burden≤ pts

Mild to moderate anticholinergic burden (ACB 1-2)

High Priority Review≤ pts

High anticholinergic burden (ACB ≥ 3) or presence of PIM

Need Clinical Suite Access?

Run this calculator with patient history, laboratory integration, and drug interaction safety checks on the DexaMed clinician app.

Open in Web App

Clinical Decision Support (CDS) Notice & Legal Disclaimer

This medical calculator and its scoring interpretation are provided strictly for licensed healthcare professionals and medical trainees as an educational and clinical decision support instrument. It does not replace independent clinical judgment, comprehensive patient history, physical examination, or attending physician oversight. Not FDA-cleared as an autonomous diagnostic medical device. Read the full DexaMed Medical Disclaimer.